Phase III Study Comparing the Efficacy and Safety of LA-EP2006 and Peg-Filgrastim
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Chemotherapy-induced Neutropenia|Breast Cancer
Interventions: DRUG: LA-EP2006|DRUG: Neulasta®
Sponsor: Sandoz
Collaborators: Sandoz GmbH